KRT19 and cancer: Even though K13/K19 bind to both mutant and WT KRAS, they only prevent RAS-dependent signalling in KRAS mutant cancer cells (HCT116) and do not affect RAS signalling in RASWT cancer cells (MCF-7) (Fig. 5).